Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_assertion type Assertion NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_head.
- NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_assertion description "[We have studied the mutational status of TET2 (complete coding region), ASXL1 (exon12), IDH1 (R132), IDH2 (R140 and R172), and c-CBL (exons 8 and 9) in 62 MPN patients (52 essential thrombocythemia (ET), five polycythemia vera (PV), and five primary myelofibrosis (PMF)) negative for both JAK2 (V617F and exon 12) and MPL (exon 10) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_provenance.
- NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_assertion evidence source_evidence_literature NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_provenance.
- NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_assertion SIO_000772 21904853 NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_provenance.
- NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_assertion wasDerivedFrom befree-20150227 NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_provenance.
- NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_assertion wasGeneratedBy ECO_0000203 NP978560.RAAWKh17PWoruPl9XBU1dwti6GmbsXjwiJl5-QC9ZLkY8130_provenance.